February 24, 2022 07:27 AM EST
FDA+

Cana­da wants to clear the way for more de­cen­tral­ized clin­i­cal tri­als: Will the US fol­low suit?

Zachary Brennan

Senior Editor

The clin­i­cal tri­al ecosys­tem in North Amer­i­ca was up­end­ed quick­ly by Covid-19, cast­ing a gi­ant spot­light on in­ef­fi­cien­cies and the need to make room for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

Met­sera rais­es $215M for stud­ies of GLP-1 and amylin obe­si­ty drugs

Adap­ti­m­mune's sec­ond T cell re­cep­tor cell ther­a­py for rare sar­co­mas pass­es piv­otal test

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

J&J takes 340B fight with fed­er­al gov­ern­ment to court

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times